| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.4 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |